ArticleJournal of clinical microbiology2011
Confirmation and follow-up of neurocysticercosis by real-time PCR in cerebrospinal fluid samples of patients living in France.
Article in Journal of clinical microbiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 47 citations in OpenAlex.
- Role of Advanced Multimodality Synthetic MRI and Dynamic Contrast-Enhanced MRI Derived Parameters in the Differentiating Neurocysticercosis and Tuberculomas.Clinical neuroradiology · 2026Article
- Molecular prevalence ofFrontiers in veterinary science · 2025Article
- Concomitant Parenchymal, Subarachnoid, and Ventricular Neurocysticercosis in Rome, Italy: A Case Report with a 4-Year Follow-Up.Tropical medicine and infectious disease · 2024Article
- Next-generation sequencing of cerebrospinal fluid for the diagnosis and monitoring of neurocysticercosis.Acta neurologica Belgica · 2024Article
- Neurocysticercosis Diagnosis in a Non-Endemic Country: France.Pathogens (Basel, Switzerland) · 2023Article
- Next-generation sequencing combined with serological tests based pathogen analysis for a neurocysticercosis patient with a 20-year history:a case report.BMC neurology · 2021Article
- Collaborative Studies for the Detection ofMicroorganisms · 2021Article
- Subarachnoid neurocysticercosis: emerging concepts and treatment.Current opinion in infectious diseases · 2020Review
- Taenia solium Cysticercosis and Its Impact in Neurological Disease.Clinical microbiology reviews · 2020Review
- A Novel, Highly Sensitive Quantitative Polymerase Chain Reaction Assay for the Diagnosis of Subarachnoid and Ventricular Neurocysticercosis and for Assessing Responses to Treatment.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020Article
- Prevalence of, and Factors Associated with Intestinal Parasites in Multinational Expatriate Workers in Al Ain City, United Arab Emirates: An Occupational Cross-Sectional Study.Journal of immigrant and minority health · 2020Article
- Neurocysticercosis Diagnosed byCase reports in infectious diseases · 2020Article
- Isolated Cerebral Alveolar Echinococcosis.Open forum infectious diseases · 2019Article
- Next generation sequencing based pathogen analysis in a patient with neurocysticercosis: a case report.BMC infectious diseases · 2018Article
- Next-Generation Sequencing of Cerebrospinal Fluid for the Diagnosis of Neurocysticercosis.Frontiers in neurology · 2018Article
- Present status of laboratory diagnosis of human taeniosis/cysticercosis in Europe.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2017Review
- Validity of a PCR assay in CSF for the diagnosis of neurocysticercosis.Neurology(R) neuroimmunology & neuroinflammation · 2017Article
- Report of three imported cases of neurocysticercosis in Guadeloupe.BMC infectious diseases · 2017Article
- Pediatric neurocysticercosis: current challenges and future prospects.Pediatric health, medicine and therapeutics · 2016Review
- Molecular testing for clinical diagnosis and epidemiological investigations of intestinal parasitic infections.Clinical microbiology reviews · 2014Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 6 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neurocysticercosis diagnosis is based on a combination of clinical, epidemiological, radiological, and immunological findings. We describe a real-time PCR assay for the confirmation of neurocysticercosis diagnosis in cerebrospinal fluid. The assay, tested on samples from nine patients living in France and diagnosed with neurocysticercosis, had a detection rate of 83.3% and 100% specificity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.